EGFR Mutation in Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma is a malignant tumor of the nasopharynx. However, while radiotherapy is the primary choice of treatment, the treatment may fail due to distant metastasis in most patients at an advanced stage. Treatment agents against some mutations have led to the development of personalize...
Main Authors: | Evren Uzun, Suna Erkilic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Molecular Pathology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-5261/3/4/17 |
Similar Items
-
From Juvenile Nasopharyngeal Angiofibroma to Nasopharyngeal Carcinoma; A Rare Case Report of Nasopharyngeal Mass
by: Saleh Mohebbi, et al.
Published: (2019-10-01) -
Cutaneous Metastases from Nasopharyngeal Carcinoma: A Rare Manifestation
by: Halimuddin Sawali, et al.
Published: (2010-12-01) -
Nasopharyngeal Myoepithelial Carcinoma Mimicking Nasopharyngeal Carcinoma
by: Chieh-Sheng Lu, et al.
Published: (2015-12-01) -
Nasopharyngeal Mucoepidermoid Carcinoma: A Rare Case Report
by: Mitat Arıcıgil, et al.
Published: (2024-04-01) -
Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01)